Literature DB >> 17448184

Botulinum toxin in headache treatment: the end of the road?

Alexander Mauskop.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17448184     DOI： 10.1111/j.1468-2982.2007.01290_1.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN： 0333-1024            Impact factor:   6.292


× No keyword cloud information.
  3 in total

1.  Expression and purification of recombinant TAT-BoNT/A(1-448) under denaturing and native conditions.

Authors:  Parvaneh Saffarian; Shahin Najar Peerayeh; Jafar Amani; Firooz Ebrahimi; Hamid Sedighianrad; Raheleh Halabian; Abbas Ali Imani Fooladi
Journal:  Bioengineered       Date:  2016-08-26       Impact factor: 3.269

Review 2.  Use of botulinum toxin A in adult neurological disorders: efficacy, tolerability and safety.

Authors:  Wilhelm J Schulte-Mattler
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

3.  Neurologic uses of botulinum neurotoxin type A.

Authors:  John P Ney; Kevin R Joseph
Journal:  Neuropsychiatr Dis Treat       Date:  2007-12       Impact factor: 2.570
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.